With regard to plasma lipid levels, our study showed that gugulipid administration caused hypercholesterolemia rather than reducing total and LDL cholesterol levels or changing LDL receptor expression in male wild-type, as well as ApoE KO, mice. This evidence concerns the gene LDLR and Hypercholesterolemia.